Glyburide, or glibenclamide, is a second-generation sulfonylurea approved by the Food and Drug Administration (FDA) for treating type 2 diabetes
Micronase
See full prescribing information for GLYBURIDE AND METFORMIN Table of Contents
Drug class: Sulfonylureas
anger, stubbornness, or sadness
Glyburide tablets USP are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2
Glyburide USP is a
A cyberattack on a unit affiliated with UnitedHealthcare, the nation’s largest insurer, has disrupted drug prescription orders at thousands of
Refer to the dabrafenib prescribing information for recommended dabrafenib dosing information
See full prescribing information for GLYBURIDE AND METFORMIN Table of Contents
• If lactic acidosis is suspected, discontinue glyburide and metformin hydrochloride and institute general supportive measures in a hospital setting
Juvenile Rheumatoid Arthritis 2
17
1
JANUVIA has not been studied in patients with a history of pancreatitis
3
3 Nursing Mothers
10 OVERDOSAGE 11 DESCRIPTION • See Full Prescribing Information for important administration instructions
3 Recommended Dosage
Important Limitations of Use: • LEVEMIR is not recommended for the treatment of diabetic ketoacidosis
Steps to reduce the risk of and manage metformin-associated lactic acidosis in these high risk groups are provided in the Full Prescribing Information
Diabetes develops when the body's ability to burn sugar declines and the unused sugar builds up
Steps to reduce the risk of and manage metformin-associated lactic acidosis in these high risk groups are provided in the Full Prescribing Information
Glyburide is an oral antihyperglycemic drug of the sulfonylurea class
2% given as add-on therapy to metformin, and 2
1 indications and usage
• If lactic acidosis is suspected, discontinue glyburide and metformin hydrochloride and institute general supportive measures in a hospital setting
Doses >10 mg/day may be given in divided doses